A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Clinical trial NCT02006472 · COMPLETED

Trial details

NCT number: NCT02006472
Sponsor: Prilenia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington's Disease

Start date: 2014-02-28
Primary completion: 2015-12-16
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.